
About Celtiss Therapeutics Private Limited
Data last updated:
Celtiss Therapeutics Private Limited is a private limited company based in Hyderabad, Telangana, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 March 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2018PTC123064. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors Shailaja Sayam Sekhar and Sayam Chandra Sekhar.
Its last annual general meeting (AGM) was held on 29 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at # 12 – 1 – 7/4 Arunodaya Nagar Nagole, Hyderabad, Telangana, India – 500068.
As per the financials filed for FY 2019, the company reported a revenue of ₹50.64 Lakh. For the same year it recorded a net loss of ₹2.14 Cr (net margin -423.3%) and EBITDA of -₹2.14 Cr (EBITDA margin -421.8%).
The company has about 4 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Celtiss. Court records list 4 cases involving the company, including 1 filed by the company and 3 filed against it; 2 cases are pending. The company has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹49 Lakh; the latest was in September 2020.
Celtiss Therapeutics Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0051366). For more details, the company can be reached via its website celtisslimited.com.
Company details
Recognitions & Rankings of Celtiss Therapeutics
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-TS-02-0051366
Contact details
Celtiss Therapeutics Private Limited's registered office is in Hyderabad, Telangana. Its website is celtisslimited.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address# 12 – 1 – 7/4 Arunodaya Nagar Nagole, Hyderabad, Telangana, India – 500068
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Celtiss Therapeutics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Celtiss Therapeutics operates one associated brand: Celtiss. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Creates innovative technologies for drug delivery patches and films. | celtisslimited.com |
Business activity
The main business activity of Celtiss Therapeutics is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Celtiss Therapeutics Private Limited, buy the company report.
Financials of Celtiss Therapeutics Private Limited
FY 2019 filings availableCeltiss Therapeutics Private Limited reported revenue of ₹50.64 Lakh for FY 2019.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ₹50.64 Lakh | |
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹2.14 Cr | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹2.14 Cr | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -421.8% | |
| Net Profit Margin | -423.3% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Celtiss Therapeutics Private Limited, buy the company report.
Board of directors of Celtiss Therapeutics Private Limited
Celtiss Therapeutics has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shailaja Sayam Sekhar | Director | 16 Mar 2018 | 8 Years 8 Months | Current |
| Sayam Chandra Sekhar Also directs: Isocare Medical Services Private Limited | Director | 16 Mar 2018 | 8 Years 8 Months | Current |
Auditor
Celtiss Therapeutics Private Limited is audited by NANDOORI & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NANDOORI & ASSOCIATES | FY 2019 | 019141S |
Shareholding
The shareholding of Celtiss Therapeutics Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Celtiss Therapeutics Private Limited, buy the company report.
Deals & funding
Celtiss Therapeutics Private Limited has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹49 Lakh; the latest was in September 2020.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2020 | Funding round | ₹49 Lakh | Investors: 2 individuals |
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Celtiss Therapeutics Private Limited has 4 court cases on record: 1 filed by Celtiss Therapeutics, 3 filed against it. 2 cases are pending and 2 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 3 | 2 |
| High courts | 1 | 0 | 0 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Rangareddy, Telangana | Court case (STC-NI) | Filed against the company by M/S. Xeel Pharma | Pending |
| District court, Medchal Malkajgiri, Telangana | Cheque dishonour complaint | Filed against the company by M/S. Xeel Pharma | Pending |
| High Court, TELANGANA | Writ petition | Filed by the company against State of Telangana and 6 others | Disposed |
| District court, Hyderabad Central, Telangana | Court case (STC - NI) | Filed against the company by Sri Sai Tejas Travels and Tours Pvt.Ltd, Rep.By Sri.R.Dhananjay | Disposed |
To see the full case history of Celtiss Therapeutics Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Celtiss Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Celtiss Therapeutics Private Limited has a workforce of 4 employees on its EPFO records as of Aug 2020, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2020-21 | 4 |
| FY 2019-20 | |
| FY 2018-19 |
To see the full employee and EPFO history of Celtiss Therapeutics Private Limited, buy the company report.
GST
Celtiss Therapeutics has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Celtiss Therapeutics Private Limited, buy the company report.
Recent activity
Celtiss Therapeutics Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Sayam Chandra Sekhar was appointed as Director on 16 Mar 2018.
Frequently asked questions
Celtiss Therapeutics is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 March 2018 (8+ years old) and is registered under CIN U74999TG2018PTC123064.
Celtiss Therapeutics has 2 current directors:
- Shailaja Sayam Sekhar - Director
- Sayam Chandra Sekhar - Director
The latest financial statements of Celtiss Therapeutics on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 29 September 2019. Year-wise statements from FY 2018 are in the company report.
No. Celtiss Therapeutics has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Celtiss Therapeutics is U74999TG2018PTC123064. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Celtiss Therapeutics has 4 court cases on record: 1 filed by the company and 3 filed against it. 2 are pending. Most are in the district courts.
Celtiss Therapeutics was incorporated on 16 March 2018, making it 8+ years old. It is registered with the Registrar of Companies, Hyderabad.
Celtiss Therapeutics has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹49 Lakh; the latest was in September 2020.
Sayam Chandra Sekhar was appointed as Director on 16 Mar 2018. Shailaja Sayam Sekhar was appointed as Director on 16 Mar 2018.
Yes, Celtiss Therapeutics is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

